journal article·2017-02

Structural, physical and antibacterial properties of pristine and Ag + doped fluoroapatite nanomaterials

Renata Wojnarowska-Nowak, Joanna Rzeszutko, Adriana Barylyak, Ganna Nechyporenko, Viktor Zinchenko, Danuta Leszczyńska, Yaroslav Bobitski, Małgorzata Kus-Liśkiewicz

Publisher page

Abstract

Calcium phosphate ceramics, owing to their resemblance to bone structure, are widely used for different biomedical applications. However, such a specific bone-structure pattern is making those materials susceptible to colonisation by pathogenic bacteria. This work presents results of the study on physical characterisation and microbiological assessment of biocide properties of modified man-made fluor- and hydroxyapatites. The structures and physical properties were characterised by a diffuse reflectance spectra, FTIR, Raman spectroscopy, TEM and Zeta-potential analyses. The bactericidal properties were assessed with Staphylococcus aureus , the main pathogenic species responsible for implant-associated infections. It was found that manufactured materials had structures typical for the biological (bone) apatites. Doping with silver has not changed their morphology. Results from the assays have confirmed that built-in silver substantially increased their biocidal properties, thus Ag-doped fluorapatite is a promising new resistant biomaterial with great bactericidal effect that potentially could be applied in tissue engineering, or dentistry.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Microelectronics and Nanotechnology, University of Rzeszow, Rzeszow, Poland

Department of Biotechnology, Biotechnology Centre for Applied and Fundamental Scie, University of Rzeszow, Kolbuszowa, Poland

Department of Therapeutic Dentistry, Danylo Halytskyy Lviv National Medical University, Lviv, Ukraine

A. V. Bogatsky Physico-Chemical Institute of NAS of Ukraine, Odessa, Ukraine

Department of Civil and Environmental Engineering, Jackson State University, Jackson, USA

Department of Photonics Lviv Politechnic National University, Lviv, Ukraine

References (66)

Show source-provided references
1. Thamaraiselvi TV, , Rajeswari S. Biological evaluation of bioceramic materials – a review. Trends Biomater Artif Organs. 2004;18(1):9–17.
2. 10.1179/1743676115Y.000000005910.1179/1743676115Y.0000000059 ↗
3. 10.1179/1743676115Y.000000002810.1179/1743676115Y.0000000028 ↗
4. 10.3109/00016357.2013.86397010.3109/00016357.2013.863970 ↗
5. 10.1016/j.jdent.2012.03.00910.1016/j.jdent.2012.03.009 ↗
6. 10.1007/s00784-015-1603-410.1007/s00784-015-1603-4 ↗
7. 10.1016/j.toxlet.2011.11.00210.1016/j.toxlet.2011.11.002 ↗
8. 10.1016/j.biomaterials.2015.02.07210.1016/j.biomaterials.2015.02.072 ↗
9. 10.1177/002203450832940610.1177/0022034508329406 ↗
10. 10.1016/j.apsusc.2015.02.06510.1016/j.apsusc.2015.02.065 ↗
11. 10.1179/1743676111Y.000000002310.1179/1743676111Y.0000000023 ↗
12. 10.1002/jbm.b.3036510.1002/jbm.b.30365 ↗
13. 10.1007/s10856-013-5079-y10.1007/s10856-013-5079-y ↗
14. 10.1016/j.msec.2013.08.02610.1016/j.msec.2013.08.026 ↗
15. 10.1016/j.actbio.2011.03.01910.1016/j.actbio.2011.03.019 ↗
16. 10.1016/j.jconrel.2006.04.00710.1016/j.jconrel.2006.04.007 ↗
17. 10.1016/j.biomaterials.2005.09.00310.1016/j.biomaterials.2005.09.003 ↗
18. 10.1016/j.apsusc.2013.02.13010.1016/j.apsusc.2013.02.130 ↗
19. 10.1016/j.apsusc.2010.12.11310.1016/j.apsusc.2010.12.113 ↗
20. 10.1007/s10856-011-4327-210.1007/s10856-011-4327-2 ↗
21. 10.1111/j.1600-0722.2011.00903.x10.1111/j.1600-0722.2011.00903.x ↗
22. Montazeri N, , Jahandideh R, , Biazar E. Synthesis of fluorapatite-hydroxyapatite nanoparticles and toxicity investigations. Int J Nanomedicine. 2011;6:197–201.
23. 10.1302/0301-620X.79B4.079065410.1302/0301-620X.79B4.0790654 ↗
24. 10.1016/j.msec.2012.12.01810.1016/j.msec.2012.12.018 ↗
25. 10.1016/j.biomaterials.2005.11.04410.1016/j.biomaterials.2005.11.044 ↗
26. Mozafari M, , Moztarzadeh F. Silver-doped bioactive glasses: what remains unanswered? Interceram. 2013;62:423–425.
27. 10.1016/j.apsusc.2014.07.02710.1016/j.apsusc.2014.07.027 ↗
28. 10.1016/j.apsusc.2014.04.06610.1016/j.apsusc.2014.04.066 ↗
29. 10.1007/s13204-013-0197-x10.1007/s13204-013-0197-x ↗
30. Ye B, , Cui K, , Feng QL, Synthesis and high temperature resistance properties of silver loaded fluorapatite antibacterial. J Inorg Mater. 2003;18:485–489.
31. 10.1016/j.ceramint.2013.04.08810.1016/j.ceramint.2013.04.088 ↗
32. 10.1016/j.apsusc.2012.03.15810.1016/j.apsusc.2012.03.158 ↗
33. 10.1016/j.apsusc.2013.11.08110.1016/j.apsusc.2013.11.081 ↗
34. 10.1021/cg060008610.1021/cg0600086 ↗
35. 10.1111/j.1744-7402.2012.02821.x10.1111/j.1744-7402.2012.02821.x ↗
36. 10.1016/j.msec.2014.01.01810.1016/j.msec.2014.01.018 ↗
37. 10.1021/cm048776c10.1021/cm048776c ↗
38. 10.1016/j.apsusc.2014.06.07510.1016/j.apsusc.2014.06.075 ↗
39. Nechyporenko GV, , Zinchenko VF. Novel synthesis method and biomedical applications of doped and undoped hydroxyapatites and fluorapatites. In: Riga Latvia, , Dekhtyar Y, , Katashev A, , Lancere L, editors. International symposium on biomedical engineering and medical physics, 10–12 October 2012. Berlin: Springer; 2013. p. 170–173.
40. 10.1002/(SICI)1097-4636(19981205)42:3<412::AID-JBM10>3.0.CO;2-I10.1002/(SICI)1097-4636(19981205)42:3<412::AID-JBM10>3.0.CO;2-I ↗
41. 10.1186/s11671-015-0770-110.1186/s11671-015-0770-1 ↗
42. 10.1016/j.jdsr.2015.03.00410.1016/j.jdsr.2015.03.004 ↗
43. Liang W, , Niu Y, , Ge S, Effects of hydrothermal treatment on the properties of nanoapatite crystals. Int J Nanomed. 2012;7:5151–5158.
44. 10.1016/j.matchemphys.2011.11.05110.1016/j.matchemphys.2011.11.051 ↗
45. 10.1016/j.biomaterials.2005.03.04110.1016/j.biomaterials.2005.03.041 ↗
46. 10.1186/1746-160X-5-1310.1186/1746-160X-5-13 ↗
47. Zahid A. Calcium phosphates in biological and industrial systems. B.K.A. Publishers, editor. New York (NY): Springer Science+Business Media; 1998. p. 85–94.
48. 10.1098/rsfs.2012.001210.1098/rsfs.2012.0012 ↗
49. 10.1016/j.cap.2007.10.07610.1016/j.cap.2007.10.076 ↗
50. 10.1016/S0142-9612(02)00232-610.1016/S0142-9612(02)00232-6 ↗
51. 10.1016/j.foodchem.2008.03.00510.1016/j.foodchem.2008.03.005 ↗
52. 10.1016/j.actbio.2007.07.01110.1016/j.actbio.2007.07.011 ↗
53. 10.1016/j.apsusc.2013.10.02910.1016/j.apsusc.2013.10.029 ↗
54. 10.1016/j.biomaterials.2007.02.02810.1016/j.biomaterials.2007.02.028 ↗
55. 10.1016/j.molstruc.2004.11.07810.1016/j.molstruc.2004.11.078 ↗
56. 10.1016/j.biomaterials.2006.11.00310.1016/j.biomaterials.2006.11.003 ↗
57. 10.4028/www.scientific.net/KEM.493-494.29310.4028/www.scientific.net/KEM.493-494.293 ↗
58. 10.1002/jbm.1028010.1002/jbm.10280 ↗
59. 10.1021/cm960425d10.1021/cm960425d ↗
60. 10.1016/j.actamat.2003.09.04610.1016/j.actamat.2003.09.046 ↗
61. 10.1016/S0022-2313(98)00055-610.1016/S0022-2313(98)00055-6 ↗
62. Theiszova M, Cytotoxicity of hydroxyapatite, fluorapatite and fluor-hydroxyapatite: a comparative in vitro study. Neoplasma. 2008;55(4):312–316.
63. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests, in approved standard–twelfth edn. Wayne (PA): CLSI Document: M02-A12; 2015. p. 1–15.
64. International A. Standard test method for determining the activity of incorporated antimicrobial agent(s) in polymeric or hydrophobic materials. In: ASTM Standard E2180–07. West Conshohocken (PA): ASTM International; 2007. p. 1–4.
65. 10.1016/j.jpha.2015.11.00510.1016/j.jpha.2015.11.005 ↗
66. 10.22203/eCM.v008a0510.22203/eCM.v008a05 ↗